Our case studies provide snapshots from the exciting work we’re doing with businesses, researchers, and government across the UK.
CASE STUDY
Unlocking global access to RNA vaccines
CPI provided state-of-the-art facilities and formulation expertise to optimise and test a novel process.
4 November 2026
CASE STUDY
Scaling-up sustainable food technology
The partnership with CPI demonstrated the digestibility and safety of MarraBio’s Caf1 proteins, supporting future novel-food approval.
4 November 2026
CASE STUDY
Scaling up e‑waste recycling through disruptive deep tech
Now DEScycle can move forward, tapping into a fast-growing e‑waste market that’s projected to reach $144 billion in value by 2028.
30 March 2025
CASE STUDY
BoobyBiome: Giving infants a healthier start in life by boosting their gut microbiome
CPI collaborated with BoobyBiome to optimise bacterial growth conditions and establish scalable methods for producing the supplement.
18 December 2024
CASE STUDY
Soteria: Revolutionising treatment of inflammatory bowel disease
Oral biologics, such as the infliximab capsule, have the potential to be life-changing for the half-a-million sufferers of Crohn’s and colitis in the UK.
18 December 2024
CASE STUDY
CPI has helped a UK-based biotechnology company develop synthetic DNA in a way that could bring genetic medicines to market at record speeds.
30 January 2024
CASE STUDY
Biodegradable plastics inspired by nature
CPI helped Chestnut Bio reduce single-use plastic with new biodegradable alternative to cable-ties in the agriculture and forestry industries.
8 December 2023
CASE STUDY
Scaling up a new process to create synthetic DNA
CPI helped Touchlight to scale-up their cell-free dbDNA process, grow their business and secure £147m private investment.
6 February 2023
CASE STUDY
Developing premium sustainable bio-packaging
Packaging matters in every sector, With over two megatons of plastic packaging waste in the UK each year, a more sustainable alternative is sorely needed.
3 February 2022
CASE STUDY
The UK’s vaccine programme has been vital in combatting COVID-19. In April 2020, CPI joined the UK Government’s Vaccine Taskforce to support the manufacture and formulation of novel mRNA vaccine candidates in the fight against the virus.
3 February 2022
CASE STUDY
When thought leaders are brought together, incredible things can happen. This is why we partner with the University of Cambridge’s Institute for Manufacturing to convene the single largest group of leading academics, researchers and industry representatives each year.
3 February 2022
CASE STUDY
Every researcher has their own unique knowledge set, bringing with them ideas and approaches that could benefit the UK. That is why collaboration and co-creation remains at the heart of the Catapult Network’s activity.
3 February 2022